Tesamorelin is the primary topic on Retapedia for the
terms listed below. This page distinguishes other meanings and
related entries.
Tesamorelin (also called TH9507, Egrifta, Egrifta SV, Egrifta WR) may refer to:
Primary topic
- Tesamorelin — Stimulates the pituitary to release growth hormone, lowering visceral (deep abdominal) fat and triglycerides. FDA-approved for HIV-associated lipodystrophy. Daily subcutaneous injection; effect reverses when stopped.
Also known as
The following names are catalogued aliases for the primary topic:
- TH9507
- Egrifta
- Egrifta SV
- Egrifta WR
External meanings
The term TH9507 may carry meanings outside this catalogue — for example, as a developmental code shared with an unrelated chemical entity, or as a trademarked product name in a different therapeutic area. Retapedia does not catalogue non-peptide compounds; consult an external reference such as PubChem or Wikidata for broader coverage.
Categories:
Disambiguation pages